Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology by Linfante, Italo
Baptist Health South Florida 
Scholarly Commons @ Baptist Health South Florida 
All Publications 
6-2020 
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: 
Emergency Preparedness for Neuroscience Teams: A Guidance 
Statement From the Society of Vascular and Interventional 
Neurology 
Italo Linfante 
Baptist Hospital of Miami; Miami Neuroscience Institute; Miami Cardiac & Vascular Institute, 
italol@baptisthealth.net 
Follow this and additional works at: https://scholarlycommons.baptisthealth.net/se-all-publications 
Citation 
Stroke (2020) 51(6):1896-1901 
This Article -- Open Access is brought to you for free and open access by Scholarly Commons @ Baptist Health 
South Florida. It has been accepted for inclusion in All Publications by an authorized administrator of Scholarly 
Commons @ Baptist Health South Florida. For more information, please contact Carrief@baptisthealth.net. 
1896
In December 2019, coronavirus disease 2019 (COVID-19), an infectious disease caused by Severe Acute Respiratory 
Syndrome Coronavirus 2 (SARS-CoV-2) caused an interna-
tional outbreak. The World Health Organization designated 
this as a global pandemic on March 11, 2020, with over 200 
countries affected worldwide. As of April 24, 2020, there were 
2 790 986 patients with confirmed COVID-19 and 195 775 
deaths worldwide, with the United States, Spain, Italy, France, 
Germany, United Kingdom, Turkey, and Iran surpassing China 
in the number of confirmed cases.1 In a consecutive series of 
221 patients with confirmed COVID-19 admitted to a hospital 
in Wuhan, China, acute ischemic stroke occurred in 11(5%) of 
patients with a broad range of stroke subtypes.2 These patients 
with stroke were older, more likely to have cardiovascular 
risk factors, presenting with severe COVID-19 with multiple 
organ involvement. Of note, presence of COVID-19 in these 
patients does not imply that COVID-19 was the mechanism 
leading to the patient’s stroke.
Shortages of Personal Protective Equipment (PPE) such 
as N95 masks, facial shields, hand sanitizer, and cleansing 
wipes have presented a major challenge in the allocation of 
resources, as healthcare workers are frontline in the treatment 
of these patients.3 Redeployment of clinical staff, nursing, 
stroke and neurocritical care specialists to care for patients 
with COVID-19 may create staffing shortages for dedicated 
stroke care.
In an effort to mitigate the spread of COVID-19 to neuro-
science healthcare workers, their patients, and their families, 
and to optimize allocation of healthcare resources, we present 
a modified algorithm to acute ischemic large vessel occlusion 
stroke workflow in the era of the COVID-19 pandemic. This 
guidance statement is based on shared best practices,4–6 con-
sensus among academic and nonacademic practicing vascular 
and interventional neurologists, literature review, and would 
be adapted to the available resources of a local institution. The 
patients with acute stroke are a vulnerable group to address 
because these patients often come emergently from the com-
munity with little information. Radical changes are felt to be 
necessary to optimize the safety of the providing team and our 
patients, limit unnecessary tests, conserve PPE resources and 
mechanical ventilator usage. This document divides into the 
following: prehospital phase to the Emergency Department 
(ED), prethrombectomy procedure, thrombectomy intrapro-
cedure, and postreperfusion therapy phases (Table).
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Table. Guidance Summary for Large Vessel Occlusion Stroke in the Era of 
COVID-19
Prehospital care
  Every patient with acute stroke (direct presenting to ED or in transfer) 
should be triaged for symptoms and signs of COVID-19, including 
potential contact.
  If there is a positive screen, this patient should wear a surgical mask and 
be placed in isolation in a negative pressure room. If telecommunication 
(phone±video) is available, it should be utilized. Identify the minimum 
number of providers needed to care for the patient and wear PPE for any 
patient contact.
  If there is a positive pulmonary symptom, consider noncontrast chest CT 
at the same time as head and neck CT/CTA, provided this addition does 
not incur >5 min delay. Note, if a patient is received in transfer from 
another hospital or has already returned from radiology, chest CT should 
not be performed before reperfusion therapies such as intravenous 
thrombolysis nor thrombectomy.*
  A direct to angiography suite approach should be considered for stable 
patients with stroke symptoms onset within 24 h, who are transferred 
from other hospitals with time from last neuroimaging within 2 h and 
ASPECTS ≥7.
Consent and health care proxy
  If the patient is not consentable, the legally authorized representative 
(LAR) should consent for the patient. Two physician emergency consent 
should be obtained if the LAR is not available.
  If the patient is consentable, perform verbal procedural consent with 
witness. Include consent for general anesthesia.
  If the patient is consentable, perform verbal healthcare proxy consent 
with a witness.
Airway preparation
  The anesthesiologist should be alerted early of a patient with COVID-19 
or suspect patient.
  Consider conscious sedation as first line if the patient is stable.
  Discuss whether there should be dedicated COVID-19 glidescope ready 
in the angio suite in case the patient deteriorates.
  In a patient who is considered at risk for airway deterioration (ie, 
orthopnea, tachypnea, or respiratory distress lying flat, high oxygen 
requirement), inability to protect airway, active vomiting, agitated or 
uncooperative, then early and controlled intubation is preferred.
  Discuss where the patient gets intubated if they need intubation 
(ie, negative pressure room before coming to angio suite, or on the 
angio table).
  Review in advance whether anesthesia presence is required in the room 
or as needed for intubation or hemodynamic issues.
Thrombectomy room preparation before patient arrival
  Remove all unnecessary objects or items in the angio suite to minimize 
need for periop team for cleaning post procedure (ie, lead aprons that 
will not be utilized).
  Cover countertop items with plastic or remove them.
  Prepare all procedural elements in the room before patient arrival (ie, 
medications, devices, cover detector, pedals with plastic, bags, etc) to 
minimize time of the patient in the room, protect room equipment, and 
prevent breaking scrub.
  Cover the cabinets of the supply closet before the patient enters the 
room.
(Continued )
  Have an observer watch provider don their gown and protective gear.
  Double gloves, a face mask, N-95 mask in COVID-19 suspect or positive 
patients, shoe covers, and protective gear should be utilized.
  Hanging lead shields and standing lead shields should be used as 
another layer of protection.
  Have hand sanitizer near the doors entering or exiting angiography or 
recovery rooms.
  Plan an area to place the phone and pager of the proceduralist in the 
control room.
Thrombectomy intraprocedure
  Keep staff to a minimum in the procedure (ie, 1 nurse, 1 technologist, 
1 physician) to minimize exposure to COVID-19, and conserve 
protective gear.
  Tape the doors to the angio suite room or with a sign so other people do 
not enter inadvertently without protective gear.
  Discuss with primary team on additional blood tests the proceduralist can 
draw off the sheath for COVID-19 and stroke workup (ie, ABG, CBC, Chem7, 
LFTs, BNP, CK in young patients, Procalcitonin, cholesterol panel, HbA1c, etc)
  Have an observer watch providers doff their gown and gear.
  Ensure any trash is completely inside the trash bag.
Neurological exam, vital sign, and access site checks post-thrombectomy
  Nonintubated, stable patients can be moved to a step-down unit with 
appropriate nursing expertise in the setting of a shortage or anticipated 
shortage of critical care beds.
  Postprocedure neurological exam and access site checks should be 
performed by one provider and minimized to conserve PPE.
  When the patient is handed off to the receiving team, have the gowned 
provider check the patient’s neurological exam, vital signs, and/or access 
site before doffing their PPE. This can count as the 15- or 30-minute 
check post-procedure depending on the time that has elapsed.
  If telecommunication/video can serve as a continuous monitor of the 
patient, it should be.
  Otherwise, consider another neurological exam, vital sign, and/or 
access site check 15 or 30 min after hand-off, and then every hour×2. 
Thereafter, these combined checks can be q4h.
  The frequency of combined neurological, vital sign, and/or access site 
checks should be adjusted depending on patient status (less if they 
are intubated and sedated), the patient’s hemodynamic stability, and 
concern for access site bleeding.
Postthrombectomy therapy
  There should be a 30-minute delay before perioperative clean staff clean 
the angio suite room to allow the room to air out.
  The patient should be extubated in a negative pressure room once they 
meet criteria.
  Postpone or delay all but absolutely necessary tests for the patient until 
they rule out for COVID-19 (to protect staff, protective gear, prevent virus 
trafficking).
  Communication with family is important as visitation rights may be 
restricted. This can take place by telephone.
  When rounding on the inpatient wards, patients on contact or droplet 
precaution should be seen at the end of rounds to avoid unintentional 
viral spread to patients not on precaution, assuming that these patients 
are medically stable.
Table. Continued
(Continued )
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Prehospital and ED Care of Acute Large Vessel 
Occlusion
Adhering to existing local protocols, all patients (including 
stroke) presenting to the ED or as interhospital transfers, are 
screened for signs and symptoms of COVID-19. Any patient 
who is COVID-19 positive or screen positive should be man-
aged under local protocols to ensure both patient and staff 
safety. Use of remote telestroke technology should be consid-
ered to obtain history and perform neurological examination, 
if available. During a Code Stroke, coordination between team 
members with predefined assigned roles (ie, one team member 
in PPE with patient, another member talks to family over tele-
phone, looks at images, laboratories, and orders thrombolysis 
or medications) will help reduce staff exposure while main-
taining quality care.
If there is positive screening for COVID-19, this patient 
should wear a surgical mask and immediately be placed in a 
negative pressure room in the ED if one is available.7 A test 
for COVID-19 should be considered if the patient meets local 
criteria for investigation. If a patient or their family is unable 
to provide corroborative history, then a surgical mask should 
be placed on this patient, the patient tested for COVID-19 and 
precautions in place.
Team members evaluating acute stroke code patients in 
person should be kept to a minimum (ie, one physician, one nurse) 
and wear appropriate PPE including full sleeved gown, surgical 
mask, eye protection (face shield or equivalent), and gloves.8 
Personal protection should be escalated to N95 mask, hair cap, 
double gloves, shoe covers in the setting of contact with patient 
with confirmed COVID-19 and/or aerosolizing events such as 
coughing, sneezing, nebulizer treatment, suctioning, nasogastric 
tube placement, bag mask ventilation, CPR, and intubation.
A dedicated computed tomography (CT) scan room for 
patients with COVID-19 should be established if multiple CT 
rooms are available. If there are positive pulmonary symp-
toms, consider low-dose chest CT at the same time as the per-
formance of CT head with CT angiography head and neck, 
as long as the addition of the chest CT does not incur >5-mi-
nute delay to treatment. CT chest may facilitate COVID-19 
diagnosis.9,10 However, decision-making to test a patient for 
COVID-19 or about need for quarantine should be based on 
local protocols. Of note, if a patient had a head CT/CT angi-
ography at an outside hospital or has returned to the ER from 
head CT/CT angiography, repeat CT to evaluate for chest pa-
thology should not be performed before reperfusion therapy 
or thrombectomy.
If CT perfusion is part of an institution’s protocol for se-
lection of thrombectomy patients in the late window, it should 
be performed at the same time as CT head and CT angiog-
raphy. Recent data suggest that in the 6- to 24-hour time 
window, clinical core mismatch by Alberta Stroke Program 
Early CT Score (ASPECTS) (6–10) on noncontrast CT over-
laps with clinical core mismatch by CT perfusion or MRI 
using DAWN criteria11 in nearly 80% of cases.12 Given the 
overwhelming benefit of thrombectomy noted in DAWN, it is 
reasonable to assume that meaningful benefit from thrombec-
tomy exists when imaging criteria defining the clinical core 
mismatch in DAWN are substituted by ASPECTS scores on 
noncontrast CT. Lack of CT perfusion or MRI capabilities in 
a resource constrained environment should not be a deterrent 
from thrombectomy in the 6- to 24-hour time window.
As it would minimize exposure to emergency department 
and CT suite personnel, a direct to the angiography suite 
approach should be considered for stable transferred patients 
with stroke symptoms onset within 24 hours, particularly if 
the time from the outside hospital imaging to arrival is <2 
hours and CT ASPECTS is ≥7. This approach has been shown 
to safely reduce times to reperfusion and may lead to better 
functional outcomes.12,13
Airway Preparation
The anesthesiologist should be alerted early of a COVID-19 or 
suspect patient. Local policies for intubation and general anes-
thesia versus conscious sedation differ at different centers. If 
appropriate, consider conscious sedation as first-line to protect 
anesthesiologists from exposure and to protect our patients from 
unnecessary intubation as well as conserving mechanical ven-
tilator resources.14,15 Converting a patient from conscious seda-
tion to general anesthesia in the middle of the procedure in the 
angiography suite should be avoided due to high risk of aerosol-
ization in a positive pressure room. In a patient who is consid-
ered at risk for airway deterioration (ie, orthopnea, tachypnea, 
or respiratory distress lying flat, high oxygen requirement), un-
able to protect their airway, agitation, uncooperative, or actively 
vomiting, then early and controlled intubation is preferred. An 
aerosol box can be used as a cover as an additional measure 
of PPE protection during intubation.16 High-flow oxygen, bag-
valve mask, and noninvasive positive pressure ventilation are 
not recommended due to the concern for aerosolization of virus. 
Rapid sequence intubation may be the preferred course.
There should be a discussion regarding where the patient 
gets intubated if it is seen necessary (ie, in a negative pressure 
room in the ED, operating theater, ICU versus angiography 
suite). If no negative pressure room is immediately available, 
the treatment plans should continue forward. Any breach in 
the ventilator tubing should be avoided, which can be a source 
for aerosolization and exposure to health care workers.
  If a provider develops symptoms of cough, fever, or shortness of 
breath, they should seek testing and potential quarantine based on 
local protocols.
Psychosocial intervention
  When appropriate, an evaluation of a patient’s mental health is important 
to alleviate the psychosocial impact of the COVID-19 pandemic for a 
patient in isolation with a new or recurrent diagnosis of stroke
  Debrief to learn from each other and perform quality improvement.
 Postacute care
  Consider testing for COVID-19 if not already done in a patient being 
transitioned to a postacute care facility to facilitate transitions of care.
ABG indicates arterial blood gas; BNP, B-type natriuretic peptide; 
CBC, complete blood count; CK, creatine kinase; COVID-19, coronavirus 
disease 2019; CTA, computed tomography angiography; ED, emergency 
department; HbA1c, hemoglobin A1c; LFT, liver function test; and PPE, 
personal protective equipment.
*See accompanying text in manuscript.
Table. Continued
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If the decision is for conscious sedation, consideration 
for a dedicated COVID-19 glidescope or video laryngoscopy 
can be prepared in the angiography suite in case the patient 
deteriorates. Advance discussion on whether the anesthesi-
ologist is required in the angiography suite during the case 
should be reviewed or as needed for intubation or hemody-
namic support. If the patient requires intubation in the angi-
ography suite, all nonessential persons should leave the room. 
Following intubation, any person entering the room should be 
in full PPE because of concern for residual aerosolization of 
virus post intubation.
Procedural Consent and Health Care Proxy
If the patient is unable to consent, a legally authorized repre-
sentative should consent for the patient. If no contact can be 
reached, 2-physician emergency consent may be obtained or 
the proper documentation for the treatment risks and benefits 
and the failed attempts to contact family can be made in the 
medical record as per local institutional protocols.
If the patient is consentable, it is preferable to have a 
patient verbally authorize staff to sign the consent form for 
them. Inanimate objects such as pens and tablets can become 
a vehicle of spread for COVID-19. This may be considered 
appropriate in the setting of the COVID-19 pandemic; how-
ever, local standards should be adhered to. The staff assistant 
would sign the patient’s name and document themselves as 
witness in the presence of the patient. If the patient declines 
directed signature, they should be provided a new pen and 
sign the form.
At the same time, as the procedural consent, consent for 
general anesthesia should be obtained.
In a consentable patient, designation of a healthcare 
proxy consent should be conducted with a staff witness in 
the event the patient loses the ability to provide informed 
consent. This step may be important because rehabilitation 
or long-term care facilities may require this document to 
accept a candidate patient.
Preprocedure Room Preparation
The charge nurse and technologist should be alerted as soon 
as there is a suspected or patient with confirmed COVID-19 
patient and room preparation dependent on the institution. If 
there are multiple angiography rooms available, a COVID-
19 room can be designated. The procedure room should be 
cleared of any unnecessary items (ie, lead aprons that will 
not be utilized) to minimize the need of perioperative staff 
cleaning post-procedure. Countertop items should be cov-
ered with plastic or removed. The detectors on the angiog-
raphy suite, foot pedal, and lead shields should be covered 
in plastic or an equivalent. The hanging lead shields and 
standing lead shields can be used as another layer of protec-
tion for the proceduralist.
The table, medications, and procedural preparation should 
be made in advance as much as possible to improve speed to 
reperfusion, limit the time the patient is in the suite, limit the 
need to break in and out of the room to retrieve materials or 
break scrub. The cabinets of the supply materials should be 
covered before the patient comes in the room.
There should be a designated space for the proceduralist 
phone and/or pager in the control room and communication 
maintained with the proceduralist via intercom or walk-
ie-talkie if there is an urgent call.
If circumstances allow, it is optimal to have an observer 
ensure proper donning of gown and protective gear by each 
member in the procedure room per institutional protocol. This 
should include double gloving, wearing a face mask that cov-
ers the eyes, N95 mask in COVID-19 suspected patients, and 
wearing shoe covers.
There should be hand sanitizer stations near the doors en-
tering or exiting the angio suite room as well as in patient 
recovery areas.
Thrombectomy Intraprocedure
In the procedure, staff should be kept to a minimum (ie, 1 
nurse, 1 technologist, 1 physician) to limit provider exposure 
and limit use of protective gear. Door entry to the angiog-
raphy suite should be taped with a sign to prevent people 
from entering inadvertently without protective gear. Most 
angiography suites are positive pressure rooms. Opening any 
doors to the angiography suite should be minimized once the 
patient is in the room to prevent movement of the virus to 
adjacent spaces.
In the control room, consider limiting the number of 
people to maintain a 6-foot distance between team members. 
These persons should wear a mask if the door between the 
angio suite and control room is opened because the angiog-
raphy suite is likely to be a positive pressure room and can 
contaminate the adjacent rooms.
Negative or even fluid balance should be maintained given 
the risk for pulmonary edema in patients with COVID-19. 
Heparinized bag flushes should be monitored closely to ensure 
inadvertent excess fluid administration. Blood loss should be 
minimized given concurrent national shortages of blood.
After the procedure is completed, discuss with the admit-
ting team and draw blood tests from the sheath that may be nec-
essary for COVID-19 and stroke workup if not already done (ie, 
arterial blood gas, complete blood count, Chem 7, creatine ki-
nase, and hypercoagulable panel in younger patients, B-type na-
triuretic peptide, troponin, hemoglobin A1c, cholesterol panel, 
etc) to limit the need for additional blood draws and exposures.
Cone-beam head CT (Xper or Dyna) should be consid-
ered while the patient is on the angiography suite table post-
procedure to obviate the need for travel to CT, with the caveat 
of limited quality.
Ensure any trash is completely inside the trash bag.
If the room is big enough, place red tape on the floor of 
the angio suite 6 feet from the patient’s bed. This would be 
the area outside of which a provider would doff their gown. 
Again, an observer to watch team members doff off their 
gown and gear can be helpful to identify potential contamina-
tion or technique mistakes, if available.
Neurological, Vital Signs, and/or Access Site 
Checks Postreperfusion Therapy
Nonintubated, stable patients can be moved to a step-down 
unit with appropriate nursing expertise in the setting of 
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a shortage or anticipated shortage of critical care beds.6 
Repatriation or transfer of a patient post-thrombectomy 
from a comprehensive stroke center to a primary stroke 
center with appropriate physician and nursing expertise can 
be considered in the setting of hospitals overwhelmed by a 
shortage of ventilators or critical care beds while maintain-
ing thrombectomy access. Communication between trans-
ferring and receiving teams, advance notification to patient 
families of repatriation is important to maintain optimal 
patient care.
Postprocedure or postthrombolytic neurological exam 
and/or access site checks should be combined and performed 
by one person and the frequency minimized to conserve 
PPE. When the patient is handed off to the receiving team, 
have the provider check the neurological exam, vitals, and/or 
access site before doffing their gown. This can qualify as the 
15- or 30-minute check post-procedure or post thrombolytic, 
depending on the time that has elapsed.
Video can be utilized as a continuing monitor of the 
patient’s neurological exam and/or access site. Otherwise, 
consider another combined exam, vital sign, and/or access site 
check 15 or 30 minutes after hand-off, and then every hour×2. 
Thereafter, if the patient has remained stable, the intervals for 
the combined checks can be spread to q4h. The frequency of 
checks should be adjusted depending on the patient’s status 
(less if they are intubated and sedated), hemodynamic sta-
bility, perceived risk of hemorrhagic transformation, and con-
cern for bleeding at the access site.
Post-Procedure
There should be a minimum 30 minutes delay before periop-
erative cleaning staff cleans the angiography suite to allow the 
room to air out.7
In-room providers should wash their hands, sanitize, and 
change out their scrubs or follow local protocol. Telephone 
communication with the patient’s family should then be pur-
sued as with any reperfusion therapy or procedure, but even 
more so with the COVID-19 pandemic and restriction of 
family/visitors.
Intubated patients should be extubated in a negative pres-
sure room.
A definitive diagnosis of COVID-19 should be made as 
soon as possible as patients who rule out will decrease the use 
of protective equipment.7 Any tests that do not change man-
agement should be delayed or deferred (to protect staff, virus 
trafficking, and conserve protective gear).7
Imaging of COVID-19 or suspected patients should be 
limited to imaging that will impact management.17
When rounding, the usual sequence is by acuity of pa-
tient illness or geographic convenience. In the era of the 
COVID-19 pandemic, assuming that all patients are equally 
stable, patients on contact or droplet precaution should be 
rounded on at the end of rounds to avoid unintentional viral 
spread to patients not on precautions as clinical circum-
stances allow.
If a provider develops any symptoms of cough, fever, or 
shortness of breath, they should seek testing and potential 
quarantine based on local protocols.
Psychosocial Intervention
When appropriate, an evaluation of a patient’s mental health is 
important to alleviate the psychosocial impact of the COVID-
19 epidemic for a patient in isolation with a new or recurrent 
diagnosis of stroke.18
It is helpful to debrief with the team to learn, improve 
best practices and workflow. Healthcare workers, particu-
larly nurses and frontline healthcare workers directly en-
gaged in the care of patients with COVID-19 are vulnerable 
to the psychological burden of depression, anxiety, in-
somnia, and distress.19
Postacute Care
In preparation for the patient’s postacute care, testing for 
COVID-19 may be required for a patient being discharged 
to a postacute care facility, regardless of whether the patient 
was being treated for COVID-19 at the hospital.20 Patients 
who are asymptomatic or with minor signs of infection 
have been shown capable of shedding potentially infectious 
virus.21 Long- or short-term care facilities are vulnerable 
to respiratory disease outbreaks, including the spread of 
COVID-19.22 Early coordinated communication between the 
primary team, case management, and postacute care facili-
ties is important to reduce bottlenecks in patient transitions 
once the patient is medically ready.
Conclusions
We live in uncharted times amidst the COVID-19 pandemic. 
The word crisis in Chinese is composed of 2 characters, one 
representing danger, the other opportunity. We cannot see this 
dangerous enemy, the coronavirus. Every opportunity and de-
tail to recalibrate our acute neurological workflow to protect 
our frontline healthcare workers, our families, our colleagues, 
and our patients should be sought, implemented, and adapted 
to a resource-constrained environment. It is incumbent upon us 
to protect each other so that we are not unknowingly exposed 
or spread to our most vulnerable patients, while at the same 
time, providing optimal care, patient safety, and access for our 
patients with stroke. Optimizing protection of the healthcare 
worker should not compromise emergency stroke patient care. 
This guidance statement pertains to current practice and can 
change as new evidence arises.
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